Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. [electronic resource]
Producer: 20200428Description: 117627 p. digitalISSN:- 1879-0631
- Amino Acid Sequence
- Antiviral Agents -- chemistry
- Betacoronavirus -- enzymology
- Binding Sites
- Coronavirus 3C Proteases
- Curcumin -- chemistry
- Cysteine Endopeptidases -- chemistry
- Drug Approval
- Drug Evaluation, Preclinical
- Drug Repositioning
- Hydrogen Bonding
- Hydrophobic and Hydrophilic Interactions
- Middle East Respiratory Syndrome Coronavirus -- enzymology
- Models, Molecular
- Molecular Docking Simulation
- Protease Inhibitors -- chemistry
- Severe acute respiratory syndrome-related coronavirus -- enzymology
- SARS-CoV-2
- Sequence Alignment
- United States
- United States Food and Drug Administration
- Viral Nonstructural Proteins -- chemistry
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.